The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV, UK: 2002-2006

Transfusion Medicine

Volumn 19, Issue 1, 2009, Pages 24-34

  Davison, K L ^a,b   Dow, B ^c   Barbara, J A ^b   Hewitt, P E ^b   Eglin, R ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Blood donors; Human T cell lymphotropic virus; Risk; Transfusion transmitted infection

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; UNITED KINGDOM;

BLOOD DONORS; BLOOD TRANSFUSION; DONOR SELECTION; GREAT BRITAIN; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; MASS SCREENING; PREVALENCE;

EID: 62549143064     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2008.00902.x     Document Type: Article

References (29)

1. Brennan, M., Runganga, J., Barbara, J.A. et al 1993) Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ (Clinical Research Ed.), 307, 1235 1239.
2. Copplestone, J.A., Prentice, A.G., Hamon, M.D., Gawler, J. Anderson, N 1994) Safe blood? HTLV-1 infection is crippling. BMJ (Clinical Research Ed.), 308, 273.
3. Davidson, F., Lycett, C., Jarvis, L.M., Kerr, D., Lumley, S., Petrik, J. Dow, B.C 2006) Detection of HTLV-I and -II in Scottish blood donor samples and archive donations. Vox Sanguinis, 91, 231 236.
4. Dougan, S., Smith, A., Tosswill, J., Davison, K., Zuckerman, M. Taylor, G 2005) New diagnoses of HTLV infection in England and Wales: 2002-2004. Eurosurveillance, 10, 232 235.
5. Dow, B.C., Munro, H., Ferguson, K., Buchanan, I., Jarvis, L., Jordan, T., Franklin, I.M. McClelland, M 2001) HTLV antibody screening using mini-pools. Transfusion Medicine, 11, 419 422.
6. Dow, B.C., Munro, H., Jarvis, L. et al 2003) The effect of leucocyte depletion of blood components and the value of donation archive samples. British Journal of Haematology, 121, 77 78.
7. Eglin, R 2002) Implementation of genome amplification technology for HCV RNA detection. Transfusion Medicine, 12, 265 273.
8. Flanagan, P., McAlpine, L., Ramskill, S.J., Smith, A.G., Eglin, R., Parry, J.V. Mortimer, P.P 1995) Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors. Vox Sanguinis, 68, 220 224.
9. Giesecke, J 1995) HTLV screening of Swedish blood donors. Lancet, 345, 978.
10. Gout, O., Baulac, M., Gessain, A. et al 1990) Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. The New England Journal of Medicine, 322, 383 388.
11. Harrison, P., Ala, F.A., Milligan, D.W. Skidmore, S 1996) HTLV-I screening in Britain. Failure to screen may be a false economy. BMJ (Clinical Research Ed.), 312, 706 707.
12. Jarvis, L.M., Dow, B.C., Cleland, A. et al 2005) Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sanguinis, 89, 128 134.
13. Kaplan, J.E., Osame, M., Kubota, H., Igata, A., Nishitani, H., Maeda, Y., Khabbaz, R.F. Janssen, R.S 1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. Journal of Acquired Immune Deficiency Syndrome, 3, 1096 1101.
14. Kurtz, J., Smith, N. Harbour, S 2000) HTLV-1 is lower in blood donors in West Midlands than South Thames. BMJ (Clinjcal Research Ed.), 321, 380 381.
15. Lee, T.H., Chafets, D.M., Busch, M.P. Murphy, E.L 2004) Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. Journal of Clinical Virology, 31, 275 282.
16. MacLennan, S 2006) What has leucodepletion done for patient? Blood Matters, 19, 9 10.
17. Manns, A., Wilks, R.J., Murphy, E.L., Haynes, G., Figueroa, J.P., Barnett, M., Hanchard, B. Blattner, W.A 1992) A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. International Journal of Cancer, 51, 886 891.
18. McMahon, E.J., Fang, C., Layug, L. Sandler, S.G 1995) Pooling blood donor samples to reduce the cost of HIV-1 antibody testing. Vox Sanguinis, 68, 215 219.
19. Mortimer, J 1997) Intersecting pools and their potential application in testing donated blood for viral genomes. Vox Sanguinis, 73, 93 96.
20. Murphy, E.L., Hanchard, B., Figueroa, J.P., Gibbs, W.N., Lofters, W.S., Campbell, M., Goedert, J.J. Blattner, W.A 1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. International Journal of Cancer, 43, 250 253.
21. Okochi, K., Sato, H. Hinuma, Y 1984) A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sanguinis, 46, 245 253.
22. Pagliuca, A., Pawson, R. Mufti, G.J 1995) HTLV-I screening in Britain. BMJ (Clinical Research Ed.), 311, 1313 1314.
23. Payne, L.J., Tosswill, J.H., Taylor, G.P., Zuckerman, M. Simms, I 2004) In the shadow of HIV-HTLV infection in England and Wales, 1987-2001. Communicable Disease and Public Health, 7, 200 206.
24. Price, J., Cant, B.A., Barbara, J.A. Tedder, R.S 2001) Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populations. Vox Sanguinis, 80, 148 150.
25. Roucoux, D.F. Murphy, E.L 2004) The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Reviews, 6, 144 154.
26. Soldan, K., Barbara, J.A., Ramsay, M.E. Hall, A.J 2003) Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sanguinis, 84, 274 286.
27. Stainsby, D., Jones, H., Asher, D. et al 2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfusion Medicine Reviews, 20, 273 282.
28. Taylor, G.P 1996) The epidemiology of HTLV-I in Europe. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13 (Suppl. 1 S8 S14.
29. Vrielink, H., Reesink, H., Habibuw, M., Schuller, M., van der, M.C. Lelie, P (1999) Comparison of four HTLV-I and HTLV-I + II ELISAs. Vox Sanguinis, 76, 187 191.